|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.878 USD | +0.23% |
|
+0.23% | +4.52% |
| Apr. 24 | BioPharma Credit, Unit to Loan up to $100 Million Each to US-based Tarsus Pharmaceuticals | MT |
| Apr. 24 | BioPharma Credit to loan USD100 million to Tarsus Pharmaceuticals | AN |
BioPharma Credit PLC reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was USD 135.73 million compared to USD 218.14 million a year ago. Net income was USD 108.45 million compared to USD 182.31 million a year ago.
Basic earnings per share from continuing operations was USD 0.0828 compared to USD 0.1336 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +4.52% | 1.08B | |
| +3.74% | 12.61B | |
| +5.50% | 9.01B | |
| -3.20% | 5.41B | |
| +2.44% | 5.25B | |
| +5.63% | 5.19B | |
| +14.36% | 4.48B | |
| +16.67% | 4.44B | |
| +1.53% | 4B | |
| +1.56% | 3.75B |
BIOPHARMA CREDIT PLC 
